Part 1. Definition
In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Part 2. Example
SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Answer: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Explanation: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.
Part 3. Exercise
SECTION 1. SHORT TITLE.

This Act may be cited as the ''Ricky Ray Hemophilia Relief Fund Act
of 1995''.

SEC. 2. FINDINGS AND PURPOSE.

(a) Findings.--The Congress finds that--
(1) approximately /2\ of all individuals in the United
States who suffer from blood-clotting disorders, such as
hemophilia, were exposed, through the use of blood-clotting
agents, to human immunodeficiency virus (HIV), which causes the
fatal illness known as acquired immune deficiency syndrome
(AIDS);
(2) the Federal Government has a shared responsibility with
the blood-products industry for protecting the safety of the
blood supply of the Nation and for regulating the safety of
blood-clotting agents;
(3) blood and blood derivatives (including blood-clotting
agents) are subject to more stringent regulation by the Federal
Government than are most products regulated under the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), because
blood and blood derivatives are subject to regulation under the
Public Health Service Act (42 U.S.C. 201 et seq.) as well as
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et
seq.);
(4) individuals with blood-clotting disorders, such as
hemophilia, were at an unusually high and largely preventable
risk of contracting HIV during the period beginning in 1980
(when technology became available to pasteurize blood-clotting
agents) and ending in 1987 (when the last mass recall of
contaminated anti-hemophilic factor (AHF) occurred);
(5) during the period beginning in 1980 and ending in 1987,
despite growing concerns about blood-borne viruses such as
hepatitis and HIV, the Federal Government did not require the
blood-products industry to use available technology to ensure
the safety of blood products that were allowed on the market
for sale to individuals with blood-clotting disorders, such as
hemophilia;
(6) the Federal Government did not require that, to allow
for fully informed decisionmaking regarding treatment options,
the blood-products industry provide directly to individuals
with blood-clotting disorders, such as hemophilia, all
available information about the risks of contaminated blood
products;
(7) the Federal Government failed to fulfill its
responsibility to properly regulate the blood-products
industry, and thus exposed individuals with blood-clotting
disorders, such as hemophilia, and their families to potential
infection with a fatal disease;
(8) 17 other developed countries have established
government compensation programs to assist individuals with
blood-clotting disorders, such as hemophilia, who were infected
with HIV;
(9) individuals with blood-clotting disorders, such as
hemophilia, who have HIV infections incur annual medical costs
that often exceed $150,000, due to the expense of the necessary
medications and the complications caused by the combination of
the 2 illnesses;
(10) Ricky Ray was born with hemophilia and, like his 2
younger brothers and thousands of others, became infected with
the deadly HIV through use of contaminated blood-clotting
products;
(11) Ricky Ray and his family have brought national
attention to the suffering of individuals with blood-clotting
disorders, such as hemophilia, and their families, who have
been devastated by HIV; and
(12) Ricky Ray died at the age of 15 on December 13, 1992,
of hemophilia-associated AIDS, and this Act should bear his
name.
(b) Purpose.--It is the purpose of this Act to establish a
procedure to make partial restitution to individuals who were infected
with HIV after treatment, during the period beginning in 1980 and
ending in 1987, with contaminated blood products.

SEC. 3. TRUST FUND.

(a) Establishment.--There is established in the Treasury of the
United States a trust fund to be known as the ''Ricky Ray Hemophilia
Relief Fund'', which shall be administered by the Secretary of the
Treasury.
(b) Investment of Amounts in Fund.--Amounts in the Fund shall be
invested in accordance with section 9702 of title 31, United States
Code, and any interest on and proceeds from any such investment shall
be credited to and become part of the Fund.
(c) Availability of Fund.--Amounts in the Fund shall be available
only for disbursement by the Attorney General under section 5.
(d) Termination.--The Fund shall terminate upon the expiration of
the 5-year period beginning on the date of the enactment of this Act.
If all of the amounts in the Fund have not been expended by the end of
the 5-year period, investments of amounts in the Fund shall be
liquidated, the receipts of such liquidation shall be deposited in the
Fund, and all funds remaining in the Fund shall be deposited in the
miscellaneous receipts account in the Treasury of the United States.
(e) Authorization of Appropriations.--There is authorized to be
appropriated to the Fund to carry out this Act $1,000,000,000.

SEC. 4. CLAIMS RELATING TO BLOOD-CLOTTING DISORDERS AND HIV.

Any individual who submits to the Attorney General written medical
documentation that the individual has an HIV infection shall receive
$125,000, from amounts available in the Fund, if each of the following
conditions is met:
(1) Characteristics of individual.--The individual is
described in 1 of the following subparagraphs:
(A) The individual has any form of blood-clotting
disorder, such as hemophilia, and was treated with
blood-clotting agents (in the form of blood components
or blood products) at any time during the period
beginning on January 1, 1980, and ending on December
31, 1987.
(B) The individual--
(i) is the lawful spouse of an individual
described in subparagraph (A); or
(ii) is the former lawful spouse of an
individual described in subparagraph (A) and
was the lawful spouse of the individual at any
time after a date, within the period described
in such subparagraph, on which the individual
was treated as described in such subparagraph.
(C) The individual acquired the HIV infection
through perinatal transmission from a parent who is an
individual described in subparagraph (A) or (B).
(2) Claim.--A claim for the payment is filed with the
Attorney General by or on behalf of the individual.
(3) Determination.--The Attorney General determines, in
accordance with section 5(b), that the claim meets the
requirements of this Act.

SEC. 5. DETERMINATION AND PAYMENT OF CLAIMS.

(a) Establishment of Filing Procedures.--The Attorney General shall
establish procedures under which individuals may submit claims for
payment under this Act. The procedures shall include a requirement that
each claim filed under this Act include written medical documentation
that the relevant individual described in section 4(1)(A) has a blood-
clotting disorder, such as hemophilia, and was treated as described in
such section.
(b) Determination of Claims.--For each claim filed under this Act,
the Attorney General shall determine whether the claim meets the
requirements of this Act.
(c) Payment of Claims.--
(1) In general.--The Attorney General shall pay, from
amounts available in the Fund, each claim that the Attorney
General determines meets the requirements of this Act.
(2) Payments in case of deceased individuals.--
(A) In general.--In the case of an individual
referred to in section 4 who is deceased at the time
that payment is made under this section on a claim
filed by or on behalf of the individual, the payment
shall be made to the estate of the individual, if such
an estate exists. If no such estate exists, the payment
may be made only as follows:
(i) If the individual is survived by a
spouse who is living at the time of payment,
the payment shall be made to such surviving
spouse.
(ii) If the individual is not survived by a
spouse described in clause (i), the payment
shall be made in equal shares to all children
of the individual who are living at the time of
the payment.
(iii) If the individual is not survived by
a person described in clause (i) or (ii), the
payment shall be made in equal shares to the
parents of the individual who are living at the
time of payment.
(B) Filing of claim by estate or survivor.--If an
individual eligible for payment under section 4 dies
before filing a claim under this Act--
(i) the estate of the individual, if such
an estate exists, may file a claim for payment
under this Act on behalf of the individual; or
(ii) if no such estate exists, a survivor
of the individual may file a claim for payment
under this Act on behalf of the individual if
the survivor may receive payment under
subparagraph (A).
(C) Definitions.--For purposes of this paragraph:
(i) The term ''spouse'' means an individual
who was lawfully married to the relevant
individual.
(ii) The term ''child'' includes a
recognized natural child, a stepchild who lived
with the relevant individual in a regular
parent-child relationship, and an adopted
child.
(iii) The term ''parent'' includes fathers
and mothers through adoption.
(3) Timing of payment.--The Attorney General may not make a
payment on a claim under this Act before the expiration of the
90-day period beginning on the date of the enactment of this
Act or after the expiration of the 5-year period beginning on
the date of the enactment of this Act.
(4) Choice of payment methods.--An individual whom the
Attorney General determines to be entitled to a payment under
subsection (c)(1) may choose to receive the payment in the form
of--
(A) a lump sum of $125,000, which shall be paid not
later than 90 days after the Attorney General
determines that the individual is entitled to receive
payment under subsection (c)(1); or
(B) 4 subpayments, of which--
(i) the 1st subpayment shall consist of
$50,000 and shall be paid not later than 90
days after the Attorney General determines that
the individual is entitled to receive payment
under subsection (c)(1); and
(ii) the 2d, 3d, and 4th subpayments
shall each consist of $25,000 and shall each be paid upon the
expiration of the 6-month period beginning on the date of the preceding
subpayment.
(d) Action on Claims.--The Attorney General shall complete the
determination required by subsection (b) regarding a claim not later
than 90 days after the claim is filed under this Act.
(e) Payment in Full Settlement of Claims Against United States.--
Payment under this Act, when accepted by an individual described in
section 4 or by the estate of or a survivor of such an individual on
behalf of the individual, shall be in full satisfaction of all claims
of or on behalf of the individual against the United States (but not
against any other person or entity) that arise out of both an HIV
infection and treatment, at any time during the period beginning on
January 1, 1980, and ending on December 31, 1987, with blood-clotting
agents (in the form of blood components or blood products).
(f) Administrative Costs Not Paid From Fund.--No costs incurred by
the Attorney General in carrying out this Act may be paid from the Fund
or set off against, or otherwise deducted from, any payment made under
subsection (c)(1).
(g) Termination of Duties of Attorney General.--The duties of the
Attorney General under this section shall cease when the Fund
terminates.
(h) Treatment of Payments Under Other Laws.--A payment under
subsection (c)(1) to an individual or an estate--
(1) shall be treated for purposes of the internal revenue
laws of the United States as damages received on account of
personal injuries or sickness; and
(2) shall not be included as income or resources for
purposes of determining the eligibility of the individual to
receive benefits described in section 3803(c)(2)(C) of title
31, United States Code, or the amount of such benefits.
(i) Use of Existing Resources.--The Attorney General should use
funds and resources available to the Attorney General to carry out the
functions of the Attorney General under this Act.
(j) Regulatory Authority.--The Attorney General may issue
regulations necessary to carry out this Act.
(k) Time of Issuance of Regulations, Guidelines, and Procedures.--
The initial regulations, guidelines, and procedures to carry out this
Act shall be issued not later than 90 days after the date of the
enactment of this Act.
(l) Judicial Review.--An individual whose claim for compensation
under this Act is denied may seek judicial review solely in a district
court of the United States. The court shall review the denial on the
administrative record and shall hold unlawful and set aside the denial
if the denial is arbitrary, capricious, an abuse of discretion, or
otherwise not in accordance with law.

SEC. 6. LIMITATION ON TRANSFER AND NUMBER OF CLAIMS.

(a) Claims Not Assignable or Transferable.--A claim under this Act
shall not be assignable or transferable.
(b) 1 Claim With Respect to Each Victim.--With respect to each
individual described in subparagraph (A), (B), or (C) of section 4(1),
the Attorney General may not pay more than 1 claim filed to receive
compensation under this Act for the harm suffered by the individual.

SEC. 7. LIMITATIONS ON CLAIMS.

The Attorney General may not pay any claim filed under this Act
unless the claim is filed within 3 years after the date of the
enactment of this Act.

SEC. 8. CERTAIN CLAIMS NOT AFFECTED BY PAYMENT.

A payment made under section 5(c)(1) shall not be considered as any
form of compensation, or reimbursement for a loss, for purposes of
imposing liability on the individual receiving the payment, on the
basis of such receipt, to repay any insurance carrier for insurance
payments or to repay any person on account of worker's compensation
payments. A payment under this Act shall not affect any claim against
an insurance carrier with respect to insurance or against any person
with respect to worker's compensation.

SEC. 9. LIMITATION ON AGENT AND ATTORNEY FEES.

Notwithstanding any contract, the representative of an individual
may not receive, for services rendered in connection with the claim of
an individual under this Act, more than 5 percent of a payment made
under this Act on the claim. Any such representative who violates this
section shall be fined not more than $50,000.

SEC. 10. DEFINITIONS.

For purposes of this Act:
(1) The term ''AIDS'' means acquired immune deficiency
syndrome.
(2) The term ''Fund'' means the Ricky Ray Hemophilia Relief
Fund.
(3) The term ''HIV'' means human immunodeficiency virus.
Answer:
Ricky Ray Hemophilia Relief Fund Act of 1995 - Establishes in the U.S. Treasury the Ricky Ray Hemophilia Relief Fund. Authorizes appropriations.
Specifies that any individual who submits to the Attorney General written medical documentation that the individual has a human immunodeficiency virus (HIV) infection shall receive $125,000 from amounts available in the Fund if the individual: (1) has a blood-clotting disorder and was treated with blood-clotting agents between January 1, 1980, and December 31, 1987; (2) is the lawful spouse of such individual or the former lawful spouse and was the lawful spouse of the individual at any time after a date within such period on which the individual was treated; or (3) acquired the HIV infection through perinatal transmission from a parent who is such an individual. Requires that a claim for payment be filed with the Attorney General by or on behalf of such individual and that the Attorney General determine that the claim meets the requirements of this Act.
Specifies that a claim under this Act shall not be assignable or transferable. Sets limits regarding the number of claims per victim. Prohibits the Attorney General from paying claims filed under this Act unless filed within three years after this Act's enactment.